Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.41USD
25 Apr 2018
Change (% chg)

$0.07 (+5.22%)
Prev Close
$1.34
Open
$1.35
Day's High
$1.41
Day's Low
$1.32
Volume
7,018
Avg. Vol
30,213
52-wk High
$6.15
52-wk Low
$1.29

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.10 December 26 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 -- -- --
(2) OUTPERFORM 1 -- -- --
(3) HOLD 0 -- -- --
(4) UNDERPERFORM 0 -- -- --
(5) SELL 0 -- -- --
No Opinion 0 -- -- --
Mean Rating 2.00 -- -- --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 2.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.10 -0.10 -0.10 --
Quarter Ending Sep-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.41 -0.41 -0.41 -1.57
Year Ending Dec-19 1 -0.32 -0.32 -0.32 -1.18

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-16 0.20 0.28 0.07 35.12
Quarter Ending Sep-16 0.42 0.20 0.22 51.65
Quarter Ending Dec-15 0.51 0.42 0.08 16.54
Quarter Ending Sep-15 0.30 0.71 0.42 141.55
Quarter Ending Mar-15 0.00 0.51 0.51 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 -- -- --
Quarter Ending Sep-18 0.00 0.00 -- -- --
Year Ending Dec-18 0.00 0.00 -- -- 2.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 -- --
Quarter Ending Sep-18 0 0 -- --
Year Ending Dec-18 0 0 -- --
Earnings